Metropolis Healthcare reports 15% growth in core business revenue during Q4FY24

12 Apr 2024 Evaluate

Metropolis Healthcare has reported around 15% growth Year-on-Year (Y-o-Y) in core business revenue during fourth quarter of FY24. Its core revenue growth was driven by volume growth around 8% and Revenue Per Patient (RPP) growth at 7% YoY for Q4FY24. RPP growth was largely driven by growth in speciality tests segment, premium wellness segment and price increase. The company’s Business-to-Consumer (B2C) revenue grew at around 18% Y-o-Y for Q4FY24. Meanwhile, the company has become debt-free in Q4FY24.  

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Metropolis Health. Share Price

1812.10 20.00 (1.12%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 348.60
Apollo Hospital Ent. 5955.00
Max Healthcare Inst 839.20
Narayana Hrudayalay 1283.80
Global Health 1461.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.